DK137081B - Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridiner. - Google Patents

Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridiner.

Info

Publication number
DK137081B
DK137081B DK48072AA DK48072A DK137081B DK 137081 B DK137081 B DK 137081B DK 48072A A DK48072A A DK 48072AA DK 48072 A DK48072 A DK 48072A DK 137081 B DK137081 B DK 137081B
Authority
DK
Denmark
Prior art keywords
hydroxy
pyridines
aminoethyl
hydroxymethyl
preparation
Prior art date
Application number
DK48072AA
Other languages
Danish (da)
English (en)
Other versions
DK137081C (enExample
Inventor
Wayne Ernest Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK137081B publication Critical patent/DK137081B/da
Application granted granted Critical
Publication of DK137081C publication Critical patent/DK137081C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK48072AA 1971-02-16 1972-02-03 Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridiner. DK137081B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11587871A 1971-02-16 1971-02-16

Publications (2)

Publication Number Publication Date
DK137081B true DK137081B (da) 1978-01-16
DK137081C DK137081C (enExample) 1978-06-19

Family

ID=22363928

Family Applications (1)

Application Number Title Priority Date Filing Date
DK48072AA DK137081B (da) 1971-02-16 1972-02-03 Analogifremgangsmåde til fremstilling af 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-aminoethyl)pyridiner.

Country Status (11)

Country Link
JP (1) JPS5518701B1 (enExample)
AR (2) AR195962A1 (enExample)
DK (1) DK137081B (enExample)
ES (1) ES399110A1 (enExample)
FI (1) FI52341C (enExample)
IL (1) IL38588A (enExample)
NO (1) NO139860C (enExample)
SE (1) SE377934B (enExample)
SU (2) SU519130A3 (enExample)
YU (2) YU35241B (enExample)
ZA (1) ZA72371B (enExample)

Also Published As

Publication number Publication date
YU35241B (en) 1980-10-31
ES399110A1 (es) 1974-12-16
NO139860B (no) 1979-02-12
YU25272A (en) 1980-04-30
AR196343A1 (es) 1973-12-18
AR195962A1 (es) 1973-11-23
SE377934B (enExample) 1975-08-04
FI52341C (fi) 1977-08-10
ZA72371B (en) 1972-09-27
YU227378A (en) 1980-10-31
IL38588A (en) 1975-02-10
SU519130A3 (ru) 1976-06-25
YU35757B (en) 1981-06-30
DK137081C (enExample) 1978-06-19
JPS5518701B1 (enExample) 1980-05-21
IL38588A0 (en) 1972-03-28
SU503518A3 (ru) 1976-02-15
FI52341B (enExample) 1977-05-02
NO139860C (no) 1979-05-23

Similar Documents

Publication Publication Date Title
DK138419B (da) Fremgangsmåde til fremstilling af 1alfa-hydroxycholecalciferol.
DK134316B (da) Fremgangsmåde til fremstilling af methylsubstituerede cuinoner.
DK131760B (da) Fremgangsmåde til fremstilling af et insulinsalt-protaminkomplex.
DK131873B (da) Fremgangsmåde til fremstilling af pullulan.
DK136981B (da) Analogifremgangsmåde til fremstilling af basisk substituerede benzylphthalazon-derivater.
DK136215B (da) Analogifremgangsmåde til fremstilling af kinolinderivater.
DK135799B (da) Fremgangsmåde til fremstilling af ethambutol.
DK127119B (da) Analogifremgangsmåde til fremstilling af 6-amino-9-benzylpurin-forbindelser.
DK133470B (da) Fremgangsmåde til fremstilling af 3alfa-hydroxy-5alfa-steroider.
DK130212B (da) Analogifremgangsmåde til fremstilling af 7-aminoindazolderivater.
DK140596B (da) Analogifremgangsmåde til fremstilling af 8beta-(ureidomethyl)-ergolenderivater.
DK138229B (da) Fremgangsmåde til fremstilling af (+)(-)-eburnamonin.
DK130959B (da) Analogifremgangsmåde til fremstilling af benzamidoacetohydroxamsyrer.
DK129794B (da) Analogifremgangsmåde til fremstilling af N-acyl-3-(piperazinoethyl)-pyrazoler.
DK133464B (da) Analogifremgangsmåde til fremstilling af nitrosourinstofderivater.
DK132221B (da) Fremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimider.
DK131296B (da) Analogifremgangsmåde til fremstilling af 3alfa-hydroxy-19-nor-5alfa-pregnan-11,20-dion.
DK131383B (da) Fremgangsmåde til fremstilling af L-tryptofan.
DK130957B (da) Fremgangsmåde til fremstilling af pregnanderivater.
DK126780B (da) Fremgangsmåde til fremstilling af flavon-7-oxyacetater.
DK130987B (da) Analogifremgangsmåde til fremstilling af 15alfa,16alfa-methylen-4-androsten-3-oner.
DK139871B (da) Analogifremgangsmåde til fremstilling af 3-isonicotinoyl-benzofuranderivater.
DK126323B (da) Fremgangsmåde til fremstilling af 3β-hydroxy-5α-cardenolider eller -bufadienolider.
DK139583B (da) Analogifremgangsmåde til fremstilling af penicilliner.
DK133809B (da) Analogifremgangsmåde til fremstilling af heterocycliske forbindelser.